US Broker Ratings

Cadence Design Systems, Inc. (CDNS) Stock Analysis: A Technology Powerhouse with Robust Growth and Investor Confidence

Cadence Design Systems, Inc. (CDNS), a leading player in the technology sector, primarily operates within the software application industry. Headquartered in San Jose, California, this American giant is making significant..

Domo, Inc. (DOMO) Stock Analysis: Navigating a High-Stakes Software Market with Cloud Innovation

Domo, Inc. (NASDAQ: DOMO) has carved out a notable presence in the technology sector with its innovative cloud-based AI and data products platform. Focused on providing real-time data and insights..

Upbound Group, Inc. (UPBD) Stock Analysis: High Dividend Yield and Substantial Upside Potential

Upbound Group, Inc. (NASDAQ: UPBD), a key player in the Technology sector within the Software – Application industry, has gained investor attention with its promising metrics and strategic market positioning...

Bentley Systems, Incorporated (BSY) Stock Analysis: Navigating Growth and Valuation Challenges

Bentley Systems, Incorporated (NASDAQ: BSY), a prominent player in the technology sector, specializes in providing infrastructure engineering software solutions worldwide. With a robust market capitalization of $17 billion, the company..

Blackbaud, Inc. (BLKB) Stock Analysis: Unveiling a 7.82% Potential Upside in the Tech Sector

Blackbaud, Inc. (NASDAQ: BLKB), a key player in the Technology sector specializing in Software – Application, offers a robust portfolio of cloud software and services. Founded in 1981 and headquartered..

Salesforce, Inc. (CRM) Stock Analysis: Unveiling a 30% Potential Upside with Robust Growth Metrics

Salesforce, Inc. (NYSE: CRM), a titan in the technology sector, has consistently maintained its position as a leader in customer relationship management solutions. With a current market capitalization of $259..

Fastly, Inc. (FSLY) Stock Analysis: Navigating the Cloud with Caution Amidst a Challenging Market

Fastly, Inc. (NYSE: FSLY) is a key player in the technology sector, particularly within the Software – Application industry. With a market cap of $1.03 billion, Fastly operates an edge..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a Potential 153.95% Upside in Biotech

Tvardi Therapeutics, Inc. (TVRD), a burgeoning player in the biotechnology sector, is making waves with a remarkable potential upside of 153.95% according to analyst ratings. Specializing in developing treatments for..

Workday, Inc. (WDAY) Stock Analysis: Exploring a 23.84% Potential Upside in the Cloud Software Sector

Workday, Inc. (NASDAQ: WDAY), a leading player in the cloud software industry, continues to capture the attention of investors with its robust suite of enterprise applications. With a market capitalization..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Evaluating the 6.15% Potential Upside for Investors

ZoomInfo Technologies Inc. (NASDAQ: GTM) stands at an interesting intersection within the technology sector, offering a sophisticated platform for go-to-market intelligence and engagement. As a key player in the software..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Navigating 18% Upside Potential Amid Digital Advertising Growth

As the digital advertising landscape continues to evolve, DoubleVerify Holdings, Inc. (NYSE: DV) stands out as a pivotal player in ensuring the effectiveness and quality of online ad investments. With..

Canopy Growth Corporation (CGC) Investor Outlook: Navigating a Potential 83% Upside

Canopy Growth Corporation (NYSE: CGC) is a name that resonates with many investors looking to capitalize on the burgeoning cannabis market. As a leader in the production, distribution, and sale..

Sapiens International (SPNS) Stock Analysis: Navigating the Software Industry with a 2.05% Dividend Yield

Sapiens International Corporation (NASDAQ: SPNS) stands as a notable player within the technology sector, specifically in the software – application industry. Headquartered in Holon, Israel, this company is known for..

Q2 Holdings, Inc. (QTWO) Stock Analysis: Balancing Growth Potential with a 5.55% Upside

For investors with an eye on the burgeoning sector of financial technology, Q2 Holdings, Inc. (NYSE: QTWO) presents a compelling opportunity. Headquartered in Austin, Texas, Q2 Holdings specializes in providing..

Roper Technologies, Inc. (ROP) Investor Outlook: Exploring a 12.94% Potential Upside in the Tech Sector

Roper Technologies, Inc. (NYSE: ROP), a key player in the Technology sector, is garnering attention from savvy investors with its impressive market cap of $60.06 billion and a promising 12.94%..

OneConnect Financial Technology (OCFT) Stock Analysis: Navigating the Road to Recovery Amidst a Potential 59% Downside

OneConnect Financial Technology Co., Ltd. (NYSE: OCFT), a prominent provider of cloud-platform-based fintech solutions in China, has been on a rollercoaster ride, with its stock recently touching a 52-week high..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring a 395% Potential Upside in the Biotech Sector

Olema Pharmaceuticals, Inc. (OLMA), a clinical-stage biopharmaceutical company, is making waves in the biotech sector with its focus on innovative therapies for women’s cancers. Positioned in the healthcare sector, Olema’s..

NICE Ltd (NICE) Stock Analysis: Exploring a 24% Potential Upside in the AI-Driven Software Sector

NICE Ltd (NASDAQ: NICE) is capturing investor attention with its robust presence in the rapidly evolving technology sector, specifically within the software applications industry. Headquartered in Ra’anana, Israel, the company..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Challenges with Strategic Potential

Zhengye Biotechnology Holding L (ZYBT), an emerging player in the healthcare sector, operates within the niche segment of drug manufacturing, specializing in veterinary vaccines. Headquartered in Jilin, China, the company..

Aura Biosciences, Inc. (AURA) Stock Analysis: A Biotech with a Potential Upside of Over 226%

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing the attention of investors with its promising biotechnology endeavors and significant upside potential. As a clinical-stage company focused on developing precision therapies for..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds